Systematic Assessment of Vascular Risk

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Thomas Lindsay, University Health Network, Toronto

ClinicalTrials.gov Identifier:

NCT00378040

First received: September 15, 2006

Last updated: May 12, 2016

Last verified: May 2016

History of Changes

Purpose

It is hypothesized that patients with vascular disease are undertreated for modifiable risk factors, leading to increased morbidity and mortality in this population.

The objective of this study is to develop a comprehensive database that will demonstrate the current adequacy of risk factor management in this high risk population, and that will provide needed guidance for future treatment options.

Condition
Peripheral Vascular Disease


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Toronto Vascular Disease Risk Factor Assessment Program: Systematic Assessment of Vascular Risk

Resource links provided by NLM:

MedlinePlus related topics: Vascular Diseases

U.S. FDA Resources

Further study details as provided by University Health Network, Toronto:


Enrollment:	800
Study Start Date:	June 2004
Study Completion Date:	December 2015
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	30 Years and older (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Those with confirmend PAD

Criteria

Inclusion Criteria:

All patients who attend the Vascular Surgery Clinic at Toronto General Hospital, St. Michael's Hospital, and St. Joseph's Health Centre who have PAD, cerebrovascular disease (CBVD), or aneurysms will be eligible for this study. Patients who are currently enrolled in other clinical studies are eligible for this study; however proper adherence to the other study will take precedence over of the current proposal.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00378040

Locations


Canada, Ontario
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4

Sponsors and Collaborators

University Health Network, Toronto

Investigators


Principal Investigator:	Thomas Lindsay, M.D	Toronto General Hospital, University Health Network

More Information


Responsible Party:	Thomas Lindsay, Professor of Surgery, University Health Network, Toronto
ClinicalTrials.gov Identifier:	NCT00378040 History of Changes
Other Study ID Numbers:	01-541S
Study First Received:	September 15, 2006
Last Updated:	May 12, 2016
Health Authority:	Canada: Health Canada
Individual Participant Data
Plan to Share IPD:	Yes
Plan Description:	See JAMA Surgery 2016 epublished First Author Dr M Hussain

Additional relevant MeSH terms:


Vascular Diseases Peripheral Vascular Diseases Peripheral Arterial Disease Cardiovascular Diseases	Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on September 27, 2016

To Top